Viewing Study NCT06393166


Ignite Creation Date: 2025-12-24 @ 4:11 PM
Ignite Modification Date: 2025-12-26 @ 9:32 AM
Study NCT ID: NCT06393166
Status: RECRUITING
Last Update Posted: 2024-05-01
First Post: 2024-04-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sequential AG and mFOLFOX Combined With Serplulimab Injection and Bevacizumab Injection in Untreated Advanced Pancreatic Cancer
Sponsor: Zhejiang Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module